APA (7th ed.) Citation

Yamasaki, T., Igarashi, K., Ogawa, O., Hasegawa, T., Fujioka, T., Takashima, S., . . . Iguchi, M. (2021). Phase II open-label study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced or metastatic urothelial carcinoma. Journal of Clinical Oncology, 39, 440. https://doi.org/10.1200/jco.2021.39.6_suppl.440

Chicago Style (17th ed.) Citation

Yamasaki, Toshinari, et al. "Phase II Open-label Study of S-588410 as Maintenance Monotherapy After First-line Platinum-containing Chemotherapy in Patients with Advanced or Metastatic Urothelial Carcinoma." Journal of Clinical Oncology 39 (2021): 440. https://doi.org/10.1200/jco.2021.39.6_suppl.440.

MLA (9th ed.) Citation

Yamasaki, Toshinari, et al. "Phase II Open-label Study of S-588410 as Maintenance Monotherapy After First-line Platinum-containing Chemotherapy in Patients with Advanced or Metastatic Urothelial Carcinoma." Journal of Clinical Oncology, vol. 39, 2021, p. 440, https://doi.org/10.1200/jco.2021.39.6_suppl.440.